3 insiders bought €8.3M of shares over the last 90 days, the latest filed 21 Sept 2026.
This page follows insider dealings at Cybin Inc. as filed with SEDI. From 18 October 2025 to 18 October 2026, the disclosure feed for Cybin Inc. logged 99 filings by 16 insiders.
Open-market activity splits into 15 purchases totalling €11.2M and 5 sales totalling €965k; 8 insiders sit on the buying side and 4 insiders on the selling side. On balance, insiders were net buyers of €10.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 6 senior executives and 2 chief executives. One trade stands out by size: a purchase of €1.2M from Halstead Michael, disclosed on 21 September 2026, or 0.14% of market capitalisation.
Across the 2,121 companies tracked on its exchange, the median is 11 filings; at 99 filings, this issuer sits above that mark. Since 2023, the database holds 15 purchases and 5 sales by insiders of the company.
In the case of 7 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 2 October 2026, 15 days ago. The median gap between a trade and its publication by SEDI is 5 days. That lag is the time during which only the insider knows about the trade.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
+2 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Cybin Inc. Strong Buy (bullish), based on 8 analysts. Average price target: CA$42.73.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended March 2026 · cache
25 of 102 declarations
Cybin Inc. is a Canadian company focused on developing psychedelic therapies for mental health disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.